In Brief
This article was originally published in The Tan Sheet
Executive Summary
GNC outperforming, issuing shares; Vitacost emerges from strategic review; Fleminger’s green tea QHC remanded back to FDA; supplement firm Modern Products unaware of GMPs; more news In Brief.
You may also be interested in...
Nutrition Market Shifting From Supplements To Whole Foods – Experts
Scientists, market researchers and attorneys see a growing consumer preference for whole plant-based foods, a movement that could cost supplements and functional foods. Communicating nutritional benefits to appease both consumers and regulators will be challenging.
Nutrition Market Shifting From Supplements To Whole Foods – Experts
Scientists, market researchers and attorneys see a growing consumer preference for whole plant-based foods, a movement that could cost supplements and functional foods. Communicating nutritional benefits to appease both consumers and regulators will be challenging.
ChromaDex Looks To Pharma Model For Commercializing Supplement Research
Nutritional ingredient developer ChromaDex is employing a pharma-style business model to expand its R&D into finished dietary supplements – with a long-term eye on pharmaceutical products. The firm’s recent hire of CEO Jeffrey Himmel was a significant step into the consumer products arena.